HDAC8 and breast carcinoma: Among the set of compounds, 45 exhibited the highest HDAC8 inhibitory potency (IC50 = 98 nM) and antiproliferative activity against MDA-MB-231 breast cancer cell line (IC50 = 230 nM) (Figure 8).